BACTERIAL CAPTURE AND ANTIGEN PRESENTATION IN SPLEEN

脾脏中的细菌捕获和抗原呈递

基本信息

  • 批准号:
    8116454
  • 负责人:
  • 金额:
    $ 37.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Clinical observations and experimental animal models implicate the spleen as an important site for host immune responses to blood-borne bacteria. How the spleen's unique tissue structure and the diverse mixture of resident myeloid and lymphoid cells work together in vivo to combat infection remains poorly understood. We expect the native tissue environment to regulate immune cell function in complex and profound ways and therefore in vivo imaging approaches are a crucial complement biochemical and in vitro studies. Using two-photon microscopy and a robust histological analysis, we propose to investigate early phagocyte clearance mechanisms, analyze the trafficking of splenic phagocytes and the role of chemokine signaling in spleen remodeling, and identify the antigen presenting cells (APCs) and tissue microenvironment involved in presenting bacteria-specific antigen to T cells. Our overall goal is to understand how spleen structure impacts immune function. Our hypothesis is that early host-pathogen interactions in the marginal zone induce bactericidal responses in some cells, while in others, those interactions trigger cell migration to the appropriate tissue microcompartments for antigen presentation. Our studies will use the well characterized Listeria model of bacterial infection, in which splenic infection leads to T cell priming and induces long-lasting immunity. The proposed studies will enhance our fundamental understanding of how the spleen responds to blood-borne bacteria and provide a framework for future studies of other more virulent human pathogens. PUBLIC HEALTH RELEVANCE: The spleen is the largest collection of lymphocytes in the human body and plays an important role in immunity to bacteria. However, few details are known regarding how resident immune cells work together to initiate the host immune response to infection. We will use cutting edge single-cell imaging techniques to study the capture of bacteria in the spleen and understand how bacterial antigen is presented to T cells.
描述(由申请方提供):临床观察和实验动物模型表明脾脏是宿主对血源性细菌免疫应答的重要部位。脾脏独特的组织结构以及固有的骨髓和淋巴细胞的多样化混合物如何在体内共同作用以对抗感染仍然知之甚少。我们期望天然组织环境以复杂和深刻的方式调节免疫细胞功能,因此体内成像方法是生化和体外研究的重要补充。使用双光子显微镜和强大的组织学分析,我们建议调查早期吞噬细胞清除机制,分析脾脏吞噬细胞的运输和趋化因子信号在脾脏重塑中的作用,并确定抗原呈递细胞(APC)和组织微环境参与细菌特异性抗原呈递给T细胞。我们的总体目标是了解脾脏结构如何影响免疫功能。我们的假设是,在边缘区的早期宿主-病原体相互作用在某些细胞中诱导杀菌反应,而在其他细胞中,这些相互作用触发细胞迁移到适当的组织微区室进行抗原呈递。我们的研究将使用表征良好的李斯特菌细菌感染模型,其中脾脏感染导致T细胞启动并诱导持久的免疫。拟议的研究将增强我们对脾脏如何对血源性细菌作出反应的基本理解,并为未来对其他更具毒性的人类病原体的研究提供框架。公共卫生相关性:脾脏是人体内淋巴细胞的最大集合,在对细菌的免疫中起着重要作用。然而,关于常驻免疫细胞如何一起工作以启动宿主对感染的免疫应答的细节知之甚少。我们将使用最先进的单细胞成像技术来研究脾脏中细菌的捕获,并了解细菌抗原如何呈递给T细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK James MILLER其他文献

MARK James MILLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK James MILLER', 18)}}的其他基金

GOBLET CELLS IN INTESTINAL IMMUNE HOMEOSTATSIS
肠道免疫稳态中的杯状细胞
  • 批准号:
    8545841
  • 财政年份:
    2012
  • 资助金额:
    $ 37.24万
  • 项目类别:
GOBLET CELLS IN INTESTINAL IMMUNE HOMEOSTATSIS
肠道免疫稳态中的杯状细胞
  • 批准号:
    8690054
  • 财政年份:
    2012
  • 资助金额:
    $ 37.24万
  • 项目类别:
GOBLET CELLS IN INTESTINAL IMMUNE HOMEOSTATSIS
肠道免疫稳态中的杯状细胞
  • 批准号:
    8422024
  • 财政年份:
    2012
  • 资助金额:
    $ 37.24万
  • 项目类别:
Lamina Propria Antigen Acquisition Pathways and Outcomes
固有层抗原获取途径和结果
  • 批准号:
    8284295
  • 财政年份:
    2011
  • 资助金额:
    $ 37.24万
  • 项目类别:
Lamina Propria Antigen Acquisition Pathways and Outcomes
固有层抗原获取途径和结果
  • 批准号:
    8488403
  • 财政年份:
    2011
  • 资助金额:
    $ 37.24万
  • 项目类别:
Lamina Propria Antigen Acquisition Pathways and Outcomes
固有层抗原获取途径和结果
  • 批准号:
    8180010
  • 财政年份:
    2011
  • 资助金额:
    $ 37.24万
  • 项目类别:
Lamina Propria Antigen Acquisition Pathways and Outcomes
固有层抗原获取途径和结果
  • 批准号:
    8678694
  • 财政年份:
    2011
  • 资助金额:
    $ 37.24万
  • 项目类别:
Lamina Propria Antigen Acquisition Pathways and Outcomes
固有层抗原获取途径和结果
  • 批准号:
    8870277
  • 财政年份:
    2011
  • 资助金额:
    $ 37.24万
  • 项目类别:
BACTERIAL CAPTURE AND ANTIGEN PRESENTATION IN SPLEEN
脾脏中的细菌捕获和抗原呈递
  • 批准号:
    8507137
  • 财政年份:
    2009
  • 资助金额:
    $ 37.24万
  • 项目类别:
BACTERIAL CAPTURE AND ANTIGEN PRESENTATION IN SPLEEN
脾脏中的细菌捕获和抗原呈递
  • 批准号:
    7735501
  • 财政年份:
    2009
  • 资助金额:
    $ 37.24万
  • 项目类别:

相似海外基金

Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
  • 批准号:
    10836880
  • 财政年份:
    2023
  • 资助金额:
    $ 37.24万
  • 项目类别:
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
  • 批准号:
    10734324
  • 财政年份:
    2023
  • 资助金额:
    $ 37.24万
  • 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
  • 批准号:
    10740465
  • 财政年份:
    2023
  • 资助金额:
    $ 37.24万
  • 项目类别:
Investigation of Target Protein Degradation and Its Effect on Enhancing Cancer-Specific Antigen Presentation by Quantitative Mass Spectrometry
通过定量质谱研究靶蛋白降解及其对增强癌症特异性抗原呈递的影响
  • 批准号:
    23K04971
  • 财政年份:
    2023
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Promoting cancer cells' antigen presentation for serving as better targets for T cell immunotherapy
促进癌细胞的抗原呈递,作为 T 细胞免疫治疗的更好靶点
  • 批准号:
    2885451
  • 财政年份:
    2023
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Studentship
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
  • 批准号:
    10385926
  • 财政年份:
    2022
  • 资助金额:
    $ 37.24万
  • 项目类别:
Lipid Antigen Presentation as a Driver of T2D Inflammation
脂质抗原呈递作为 T2D 炎症的驱动因素
  • 批准号:
    10509043
  • 财政年份:
    2022
  • 资助金额:
    $ 37.24万
  • 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
  • 批准号:
    10704008
  • 财政年份:
    2022
  • 资助金额:
    $ 37.24万
  • 项目类别:
Sex Differences in lipid antigen presentation, impact of lipid antigen presentation on peripheral lipid metabolism
脂质抗原呈递的性别差异,脂质抗原呈递对外周脂质代谢的影响
  • 批准号:
    10818273
  • 财政年份:
    2022
  • 资助金额:
    $ 37.24万
  • 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
  • 批准号:
    10349397
  • 财政年份:
    2022
  • 资助金额:
    $ 37.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了